Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

$IMTXPress releaseJul 17, 2026, 10:24 AM ETRead the release

Immatics announced that it will present three abstracts across its PRAME franchise at the upcoming ESMO Congress 2026, which will be held in Madrid from October 23-27. The data presentations will include Phase 1b results for anzu-cel in melanoma, Phase 1 results for IMA203CD8 in solid tumors, and Phase 1b data for IMA402 bispecific at the recommended Phase 2 dose.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.